Ionis Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Carlsbad, CA
IONS chart
What traders are saying about $IONS
Latest postsIonis Pharmaceuticals Inc news
- IONS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ionis Pharmaceuticals
PR Newswire ·
- What Triggered a 28% Plunge in Ionis Pharmaceuticals (NASDAQ:IONS) After It Cut Tryngolza Sales in Half?
kalkine.ca ·
- Oppenheimer Adjusts Ionis Pharmaceuticals Price Target to $70 From $85, Maintains Outperform Rating
marketscreener.com ·
- TD Cowen cuts Ionis Pharmaceuticals stock price target on Tryngolza miss
Investing.com Canada ·
- RBC cuts Ionis Pharmaceuticals stock price target on revenue miss By Investing.com
Investing.com India ·
- Wells Fargo cuts Ionis Pharmaceuticals price target on slower launch
Investing.com ·
- Ionis to present at upcoming investor conferences
Yahoo Finance ·
- Four conference talks from Ionis will stream live; replays follow within 48 hours.
Stock Titan ·
- Ionis Pharmaceuticals Inc (IONS) (Q3 2026) Earnings Call Highlights: DAWNZERA Momentum and ...
Yahoo Finance ·
- BofA cuts Ionis Pharmaceuticals stock price target on lower sales outlook
Investing.com ·
- Key facts: Ionis Q3 Loss, Mixed Trial Results; HIBSAGO Wins Approvals
TradingView ·
- What Does Ionis Pharmaceuticals (IONS) TRYNGOLZA Forecast Cut Mean For Growth?
Simply Wall St ·
Ionis Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $943.7M | $705.1M | $787.6M | $587.4M |
| Net income | -$381.4M | -$453.9M | -$366.3M | -$269.7M |
| Diluted EPS | $-2.38 | $-3.04 | $-2.56 | $-1.90 |
| Total assets (year end) | $3.52B | $3.00B | $2.99B | $2.53B |
| Cash and equivalents (year end) | $372.3M | $242.1M | $399.3M | $276.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
- 8-K8-K
- 8-K8-K
- 8-K8-K
- 8-KCURRENT REPORT FILING
- 8-K8-K
- 8-K8-K
- 10-QIONIS PHARMACEUTICALS, INC. 10-Q 06-30-2026
- 8-K8-K
- 8-K8-K
- 8-K8-K
- 8-K8-K
About Ionis Pharmaceuticals Inc
- Ticker
- IONS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carlsbad, CA
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC CIK
- 874015
- Former names
- ISIS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Ionis Pharmaceuticals Inc listed on?
Ionis Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol IONS.
What industry is Ionis Pharmaceuticals Inc in?
Ionis Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ionis Pharmaceuticals Inc headquartered?
Ionis Pharmaceuticals Inc's business address on file with the SEC is in Carlsbad, CA.
When does Ionis Pharmaceuticals Inc's fiscal year end?
Ionis Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Ionis Pharmaceuticals Inc report?
Ionis Pharmaceuticals Inc reported $943.7M in revenue for calendar year 2025, according to its SEC filings.